PARACODIN Tablet Ref.[49814] Active ingredients: Dihydrocodeine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2020  Publisher: Teofarma S.R.L., Valle Salimbene (PV), Via F. LLI Cervi, 8 CAP 27010, Italy

4.1. Therapeutic indications

Paracodin is indicated in the management of non-productive cough.

4.2. Posology and method of administration

For oral administration.

Adults and children over the age of 12 years: The usual dose is 10 to 30 mg up to three times daily.

4.9. Overdose

In the case of overdosage conservative management is recommended. Severe respiratory depression can be treated with naloxone hydrochloride 0.4 to 2 mg subcutaneously, repeated as required at 2 or 3 minute intervals.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Keep blister in the outer carton.

6.5. Nature and contents of container

Aluminium/PVC foil blister strips containing 20 tablets.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.